FDA Recalls Oasis Tears PF Eye Drops Due to Sterility Concerns

On May 20, 2024, Oasis Medical, Inc. issued a recall for its Oasis Tears PF lubricant eye drops. The company announced the action after FDA inspectors raised concerns during a recent review of the manufacturer, Excelvision. The recall centers on a specific 10mL bottle, NDC 42126-6400-1, made in France. Oasis Medical stated the recall was initiated “out of an abundance of caution” due to a lack of assurance of sterility.

What Consumers Should Do Immediately

Individuals who have this product should stop using it. Do not apply the drops to your eyes. Check the labeling on your bottle to confirm it matches the recalled product: “Oasis Tears PF, Preservative-Free Lubricant Eye Drops,” 10mL/0.34 Fl OZ, and NDC number 42126-6400-1.

You can return the product to the place of purchase for a refund or dispose of it properly. Contact Oasis Medical, Inc. at 626-335-0099 for more information regarding the recall process. The FDA encourages consumers to report any adverse reactions or quality problems to its MedWatch Safety Information and Adverse Event Reporting Program.

Potential Health Risks from Non-Sterile Eye Drops

Sterility is a non-negotiable requirement for any product designed for ocular use. The eye is a sensitive organ with limited defenses against infection. Using a product that may not be sterile introduces a direct risk of microbial contamination.

Possible consequences include eye infections such as bacterial keratitis, an infection of the cornea. This condition can cause pain, redness, blurred vision, and sensitivity to light. In serious cases, it can lead to corneal scarring, ulceration, and permanent vision loss. For individuals with pre-existing eye conditions or compromised immune systems, the risk is higher. The recall aims to prevent these potential infections before they occur.

Connecting Eye Health to Hearing and Balance Research

While this alert concerns an eye care product, it highlights a principle fundamental to all sensory health: the importance of product safety and regulatory vigilance. Research in tinnitus and hearing often examines how infections and systemic inflammatory responses can affect auditory pathways.

Uncontrolled ocular infections could, in theory, complicate systemic health for patients involved in clinical studies for auditory conditions. For our readers managing hearing health, maintaining overall wellness includes using only approved, safe medical products. This recall serves as a reminder to regularly check FDA alerts for any health products you use.

Source:
FDA Safety Alerts